Compare Viatris Inc (VTRS) vs Xpeng Inc - ADR (XPEV) Price & Performance

Viatris (VTRS) trades at $17.44, down 0.29% on the day, with a bullish technical outlook supported by moving averages and oversold RSI levels. The company has beaten earnings estimates for three consecutive quarters, though it faces profitability challenges with negative net margins. Recent positive developments include FDA approval for WAKIX in Japan and consistent dividend payments, while analyst consensus leans toward a buy rating with a $22.17 price target representing 27% upside potential.

The stock presents a value opportunity with reasonable P/S and P/B ratios, but investors must weigh strong cash generation against persistent profitability issues. Key catalysts include continued earnings beats and pipeline progress, while risks involve margin pressure and high debt levels. The current valuation disconnect between technical strength and fundamental challenges creates a balanced risk-reward profile for patient investors.

XPeng (XPEV) trades at $9.55, down 0.31% with bearish technical signals despite analyst optimism. The company shows strong revenue growth to $76.72B in 2025 but remains unprofitable with a -$1.14B net loss. Recent vehicle deliveries of 41,256 units in September 2026 and upcoming G9L SUV launch at Paris Motor Show highlight expansion efforts. Cash flow improved significantly with $8.26B from operations in 2025, though negative earnings surprises in Q1 and Q2 2026 raise execution concerns.

XPeng presents a high-risk growth opportunity with 58.8% analyst buy ratings and $17.55 price target suggesting 84% upside. However, persistent losses, competitive EV market pressures, and technical bearishness create significant headwinds. The stock's appeal hinges on successful Physical AI and robotics commercialization alongside sustained delivery growth.